Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: Key points of imaging diagnosis

Liver Cancer

Volumn 3, Issue 2, 2014, Pages 85-96

  Murakami, Takamichi ^a   Tsurusaki, Masakatsu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Benign liver tumor; Computed tomography; Hepatocellular carcinoma; Magnetic resonance imaging

Indexed keywords

GADOXETIC ACID;

ALCOHOL LIVER DISEASE; ANGIOMYOLIPOMA; BENIGN TUMOR; BILE DUCT CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; LIVER METASTASIS; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSEUDOTUMOR; REVIEW; TUMOR DIFFERENTIATION;

EID: 84910638611     PISSN: 22351795     EISSN: 16645553     Source Type: Journal    
DOI: 10.1159/000343864     Document Type: Review

References (37)

1. Lee JM, Yoon JH, Joo I, Woo HS: Recent advances in CT and MR imaging for evaluation of hepatocellular car-cinoma. Liver Cancer 2012;1:22-40.
2. Joo I, Choi BI: New paradigm for management of hepatocellular carcinoma by imaging. Liver Cancer 2012;1:94-109.
3. Dietrich CF, Mertens JC, Braden B, Schuessler G, Ott M, Ignee A: Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007;45:1139-1145.
4. Perkins AB, Imam K, Smith WJ, Cronan JJ: Color and power Doppler sonography of liver hemangiomas: a dream unfulfilled? J Clin Ultrasound 2000;28:159-165.
5. Ashida C, Fishman EK, Zerhouni EA, Herlong FH, Siegelman SS: Computed tomography of hepatic cavernous hemangioma. J Comput Assist Tomogr 1987;11:455-460.
6. Freeny PC, Marks WM: Hepatic hemangioma: dynamic bolus CT. AJR Am J Roentgenol 1986;147:711-719.
7. Itai Y, Furui S, Araki T, Yashiro N, Tasaka A: Computed tomography of cavernous hemangioma of the liver. Radiology 1980;137:149-155.
8. Leslie DF, Johnson CD, MacCarty RL, Ward EM, Ilstrup DM, Harmsen WS: Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. AJR Am J Roentgenol 1995;165:1403-1406.
9. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H: Hepatic hemangioma: findings with two-phase CT. Radiology 1995;196:465-469.
10. Tsurusaki M, Kawasaki R, Yamaguchi M, Sugimoto K, Fukumoto T, Ku Y, Sugimura K: Atypical hemangioma mimicking hepatocellular carcinoma with a special note on radiological and pathological findings. Jpn J Radiol 2009;27:156-160.
11. Cheng HC, Tsai SH, Chiang JH, Chang CY: Hyalinized liver hemangioma mimicking malignant tumor at MR imaging. AJR AmJRoentgenol 1995;165:1016-1017.
12. Ueda K, Matsui 0, Kawamori Y, Kadoya M, Yoshikawa J, Gabata T, Nonomura A, Takashima T: Differentiation of hypervascular hepatic pseudolesions from hepatocellular carcinoma: value of single-level dynamic CT during hepatic arteriography. J Comput Assist Tomogr 1998;22:703-708.
13. Tsurusaki M, Sugimoto K, Fujii M, Fukuda T, Matsumoto S, Sugimura K: Combination of CT during arterial portography and double-phase CT hepatic arteriography with multi-detector row helical CT for evaluation ofhypervascular hepatocellular carcinoma. Clin Radiol 2007;62:1189-1197.
14. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T: Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 2010;256:151-158.
15. Carlson SK, Johnson CD, Bender CE, Welch TJ: CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol 2000;174:705-712.
16. Nguyen BN, Flejou JF, Terris B, Belghiti J, DegottC: Focal nodular hyperplasia ofthe liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999;23:1441-1454.
17. Brancatelli G, Federle MP, Katyal S, Kapoor V: Hemodynamic characterization of focal nodular hyperplasia using three-dimensional volume-rendered multidetector CT angiography. AJR Am J Roentgenol 2002;179:81-85.
18. Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA: Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004;24:3-17, discussion 18-19.
19. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, Helmberger TK, Reiser MF: Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005;234:468-478.
20. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, Donato F, Colagrande S: Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012;262:520-529.
21. Kim MJ, Rhee HJ, Jeong HT: Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR AmJRoentgenol2012;199:W575-W586.
22. Caseiro-Alves F, Zins M, Rahmouni A, Vilgrain V, Menu Y, Mathieu D, Mahfouz A-E: Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 1996;198:889-892.
23. Gluud C, Christoffersen P, Eriksen J, Wantzin P, Knudsen BB: Influence of ethanol on development of hyperplastic nodules in alcoholic men with micronodular cirrhosis. Gastroenterology 1987;93:256-260.
24. Sugihara S, Nakashima 0, Kiyomatsu K, Ijiri M, Edamitsu 0, Kojiro M: A case of liver cirrhosis with a hyperplastic nodular lesion. Acta Pathol Jpn 1990;40:699-703.
25. Terada T, Kitani S, Ueda K, Nakanuma Y, Kitagawa K, Masuda S: Adenomatous hyperplasia of the liver resembling focal nodular hyperplasia in patients with chronic liver disease. Virchows Arch A Pathol Anat Histopathol 1993;422:247-252.
26. Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies SE, Burroughs AK, Watkinson A, Dhillon AP: Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 2003;42:14-21.
27. An HJ, Illei P, Diflo T, John D, Morgan G, Teperman L, Theise N: Scirrhous changes in dysplastic nodules do not indicate high-grade status. J Gastroenterol Hepatol 2003;18:660-665.
28. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V, Roskams T: Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-761.
29. Nakashima 0, Kurogi M, Yamaguchi R, Miyaaki H, Fujimoto M, Yano H, Kumabe T, Hayabuchi N, Hisatomi J, Sata M, Kojiro M: Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules? J Hepatol 2004;41:992-998.
30. Yoneda N, Matsui 0, Kitao A, Kita R, Kozaka K, Koda W, Kobayashi S, Gabata T, Ikeda H, Sato Y, Nakanuma Y: Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 2012;30:499-508.
31. Bosnian FT, Hruban RH, Theise ND: WHO Classification of Tumours of the Digestive System. Lyon, IARC, 2010.
32. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H: Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatol-ogy 2008;48:808-818.
33. van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JN: Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 2011;261:172-181.
34. Park JY, Choi MS, Lim YS, Park JW, Kim SU, Min YW, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC: Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases. Gut Liver 2014;8:58-63.
35. Kitajima K, Shiba H, Nojiri T, Uwagawa T, Ishida Y, Ichiba N, Yanaga K: Intrahepatic cholangiocarcinoma mimicking hepatic inflammatory pseudotumor. J Gastrointest Surg 2007;11:398-402.
36. Kim SA, Lee JM, Lee KB, Kim SH, Yoon SH, Han JK, Choi BI: Intrahepatic mass-forming cholangiocarcino-mas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings. Radiology 2011;260:148-157.
37. Asayama Y, Tajima T, Okamoto D, Nishie A, Ishigami K, Ushijima Y, Kakihara D, Aishima S, Taketomi A, Honda H: Imaging of cholangiolocellular carcinoma of the liver. Eur J Radiol 2010;75:el20-el25.